Detalhe da pesquisa
1.
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
N Engl J Med
; 388(10): 898-912, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36884323
2.
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Cancer
; 129(22): 3564-3573, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530385
3.
Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.
Oncologist
; 28(6): e425-e435, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869793
4.
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN.
Clin Orthop Relat Res
; 481(1): 107-116, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001000
5.
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2).
Cancer
; 128(10): 1958-1966, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201621
6.
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
Cancer
; 128(1): 85-93, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643947
7.
Treatment updates on tenosynovial giant cell tumor.
Curr Opin Oncol
; 34(4): 322-327, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35837703
8.
Primary synovial sarcoma of bone: a retrospective analysis of 25 patients.
Histopathology
; 80(4): 686-697, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34821406
9.
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial).
BMC Cancer
; 22(1): 629, 2022 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672690
10.
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis.
J Surg Oncol
; 126(8): 1520-1532, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006054
11.
Long-term outcomes of pexidartinib in tenosynovial giant cell tumors.
Cancer
; 127(6): 884-893, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33197285
12.
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.
Cancer Immunol Immunother
; 70(9): 2617-2624, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580363
13.
Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.
Ann Surg Oncol
; 28(2): 1142-1150, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32572850
14.
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab.
BMC Cancer
; 21(1): 89, 2021 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482769
15.
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial.
Acta Orthop
; 92(4): 493-499, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33977825
16.
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group.
Cancer
; 126(21): 4726-4734, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32749681
17.
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.
Lancet
; 394(10197): 478-487, 2019 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229240
18.
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic.
Oncologist
; 25(10): e1562-e1573, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888360
19.
Experience with eribulin in pretreated patients with advanced liposarcoma: a case series.
Future Oncol
; 16(1s): 25-32, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858818
20.
Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone.
Curr Treat Options Oncol
; 21(8): 68, 2020 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32623530